IMRN · NASDAQ
Immuron (IMRN) Stock Price & Fundamentals
Immuron (IMRN) closed at $251.41 on Oct 9, 2026, up 1.64% from the previous close of $247.36.
Share price, past year
1Y +9.35%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $251.41 |
| Sep 30, 2026 | $240.88 |
| Aug 31, 2026 | $242.45 |
| Jul 31, 2026 | $244.35 |
| Jun 30, 2026 | $229.68 |
| May 29, 2026 | $233.24 |
| Apr 30, 2026 | $218.40 |
| Mar 31, 2026 | $221.40 |
| Feb 27, 2026 | $222.16 |
| Jan 30, 2026 | $230.07 |
| Dec 31, 2025 | $230.50 |
| Nov 28, 2025 | $229.33 |
| Oct 31, 2025 | $223.67 |
Key statistics
- Market cap
- —
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 322.8M
- Dividend yield
- —
- 52-week range
- $215.58 – $251.41
Market cap, P/E and dividend yield aren't shown for Immuron yet: its SEC filings count its ordinary shares, which can differ from the shares traded in the US, and report in Australian dollars.
Financials
Immuron reported revenue of A$7.29M for fiscal 2025, up 48.63% from fiscal 2024.
Figures are in Australian dollars (AUD), as Immuron reports them to the SEC.
Immuron reported a net loss of A$5.22M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Jun 30, 2025 | A$7.29M | +48.6% | −A$5.22M | −71.6% | −A$2.26 | — |
| FY2024ended Jun 30, 2024 | A$4.90M | +171.7% | −A$6.94M | −141.5% | −A$3.04 | −A$5.88M |
| FY2023ended Jun 30, 2023 | A$1.80M | +135.9% | −A$3.79M | −209.8% | −A$1.66 | −A$2.60M |
| FY2022ended Jun 30, 2022 | A$765.19K | +424.9% | −A$2.85M | −373.0% | −A$1.25 | −A$3.16M |
| FY2021ended Jun 30, 2021 | A$145.78K | −94.2% | −A$8.38M | −5,751.6% | −A$3.79 | −A$4.09M |
| FY2020ended Jun 30, 2020 | A$2.52M | +24.9% | −A$2.93M | −116.2% | — | −A$3.15M |
| FY2019ended Jun 30, 2019 | A$2.02M | +38.4% | −A$4.66M | −231.0% | — | −A$1.80M |
| FY2018ended Jun 30, 2018 | A$1.46M | +4.4% | — | — | — | −A$3.51M |
| FY2017ended Jun 30, 2017 | A$1.40M | +39.5% | — | — | — | −A$6.95M |
| FY2016ended Jun 30, 2016 | A$1.00M | — | — | — | — | −A$5.16M |
Company profile
- Name
- Immuron Ltd
- Ticker
- IMRN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 62 Lygon Street, Level 3, Carlton, Victoria, C3 3053
- Incorporated in
- C3
- Fiscal year ends
- June
- SEC CIK
- 0001660046
Recent SEC filings
- Sep 24, 2026
- Sep 25, 2025
- Oct 1, 2024
- Sep 28, 2023
- Sep 9, 2022
- Oct 29, 2021
- Oct 28, 2020
- Oct 28, 2019
Frequently asked questions
What is Immuron's stock price?
Immuron (IMRN) closed at $251.41 on Oct 9, 2026, up 1.64% from the previous close of $247.36.
How much revenue does Immuron make?
Immuron reported revenue of A$7.29M for fiscal 2025, up 48.63% from fiscal 2024.
Sources and methodology
Fundamentals come from Immuron Ltd's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures